Compounds > 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone
Page last updated: 2024-09-04

3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and Cardiac Failure

3-amino-6-methyl-5-phenyl-2(1h)-pyridinone has been researched along with Cardiac Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erhardt, PW1
Botelho, LH; Herzig, JW; Solaro, RJ1

Reviews

1 review(s) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and Cardiac Failure

ArticleYear
In search of the digitalis replacement.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship

1987

Other Studies

1 other study(ies) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and Cardiac Failure

ArticleYear
Myofibrillar Ca++ activation and heart failure--Ca++ sensitization by the cardiotonic agent APP 201-533.
    Basic research in cardiology, 1989, Volume: 84 Suppl 1

    Topics: Animals; Calcium; Cardiotonic Agents; Dogs; Heart Failure; In Vitro Techniques; Liver; Myocardial Contraction; Myofibrils; Protein Kinases; Pyridones; Rats

1989